Andrew L Coveler

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Binding Protein

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Andrew L Coveler, Matthew J Reilley, Mark M Zalupski, Teresa Macarulla, Christos Fountzilas, Mariano Ponz-Sarvisé, Adnan Nagrial, Nataliya V Uboha, Sophia Frentzas, Michael James Overman, Anne M Noonan, Wells A Messersmith, Nick Pavlakis, Niharika B Mettu, Ina Bisha, Ying Wang, Paul Smith, Elina Murtomaki, Agata A Bielska, Veronique Bragulat, Zachary A Cooper, Rakesh Kumar, David R Spigel
A Phase 1b/2 Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Thomas A Abrams, Leah H Biller, Jennifer A Chan, Jeffrey A Meyerhardt, Nadine J McCleary, Wolfram Goessling, Anuj K Patel, Jeffrey S Wisch, Matthew B Yurgelun, Kent Mouw, Brendan Reardon, Eliezer Van Allen, Jessica A Zerillo, Jeffrey W Clark, Aparna Parikh, Robert J Mayer, Benjamin Schlechter, Kimmie Ng, Sunil Kumar, Catherine Del Vecchio Fitz, Charlotte Kuperwasser, Glenn J Hanna, Andrew L Coveler, Douglas A Rubinson, Emma L Welsh, Kathleen Pfaff, Scott Rodig, Stephanie K Dougan, James M Cleary
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer 12 (1) (2024)
Mary L Disis, Yushe Dang, Andrew L Coveler, Jennifer S Childs, Doreen M Higgins, Ying Liu, Jing Zhou, Sean Mackay, Lupe G Salazar
A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel, Amitkumar N Mehta, Timothy M Kuzel, Svetomir N Markovic, Olivier Rixe, David L Bajor, Thomas F Gajewski, Martin Gutierrez, Hun Ju Lee, Ajay K Gopal, Paolo Caimi, Elisabeth I Heath, John A Thompson, Sahar Ansari, Celine Jacquemont, Ariel Topletz-Erickson, Peigen Zhou, Michael W Schmitt, Juneko E Grilley-Olson
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas. Journal for immunotherapy of cancer 11 (6) (2023)
Mary L Disis, Yushe Dang, Andrew L Coveler, Jennifer S Childs, Doreen M Higgins, Ying Liu, Jing Zhou, Sean Mackay, Lupe G Salazar
A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Mary L Disis, Yushe Dang, Andrew L Coveler, Jennifer S Childs, Doreen M Higgins, Ying Liu, Jing Zhou, Sean Mackay, Lupe G Salazar
A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Floris S Verheij, Dana M Omer, Hannah Williams, Sabrina T Lin, Li-Xuan Qin, James T Buckley, Hannah M Thompson, Jonathan Benjamin Yuval, Jin K Kim, Richard F Dunne, Jorge E Marcet, Peter Cataldo, Blasé N Polite, Daniel O Herzig, David Liska, Samuel Oommen, Charles M Friel, Charles A Ternent, Andrew L Coveler, Steven Hunt, Anita Gregory, Madhulika G Varma, Brian L Bello, Joseph C Carmichael, John C Krauss, Ana Gleisner, José G Guillem, Larissa Temple, Karyn A Goodman, Neil H Segal, Andrea Cercek, Rona Yaeger, Garrett M Nash, Maria Widmar, Iris H Wei, Emmanouil P Pappou, Martin R Weiser, Philip B Paty, J Joshua Smith, Abraham Jing-Ching Wu, Marc J Gollub, Leonard B Saltz, Julio Garcia-Aguilar
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Benedito Arruda Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, Anwaar Saeed, Howard Safran, Wen Wee Ma, Andrew L Coveler, Steven Francis Powell, Bruno R Bastos, Elizabeth J Davis, Vaibhav Sahai, William Mikrut, James Longstreth, Sheri Smith, Taylor M Weiskittel, Hu Li, Brittany A Borden, Robert Donald Harvey, Solmaz Sahebjam, Andres Cervantes, Austin Koukol, Andrew P Mazar, Neeltje Steeghs, Razelle Kurzrock, Francis J Giles, Pamela N Munster
Phase 1 study of Elraglusib (9-ING-41), a glycogen synthase kinase-3b inhibitor, as monotherapy or combined with chemotherapy in patients with advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Julio Garcia-Aguilar, Sujata Patil, Marc J Gollub, Jin K Kim, Jonathan Benjamin Yuval, Hannah M Thompson, Floris S Verheij, Dana M Omer, Meghan Lee, Richard F Dunne, Jorge E Marcet, Peter Cataldo, Blasé N Polite, Daniel O Herzig, David Liska, Samuel Oommen, Charles M Friel, Charles A Ternent, Andrew L Coveler, Steven Hunt, Anita Gregory, Madhulika G Varma, Brian L Bello, Joseph C Carmichael, John C Krauss, Ana L Gleisner, Philip B Paty, Martin R Weiser, Garrett M Nash, Emmanouil Pappou, José G Guillem, Larissa Temple, Iris H Wei, Maria Widmar, Sabrina T Lin, Neil H Segal, Andrea Cercek, Rona Yaeger, J Joshua Smith, Karyn A Goodman, Abraham Jing-Ching Wu, Leonard B Saltz
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (23) (2022)
Robin Park, Andrew L Coveler, Ludimila Cavalcante, Anwaar Saeed
GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties. Biology 10 (7) (2021)
Andrew L Coveler, Jonathan Mizrahi, Bory Eastman, Smith Jim Apisarnthanarax, Shalini Dalal, Terry McNearney, Shubham Pant, null null
Pancreas Cancer-Associated Pain Management. The oncologist 26 (6) (2021)
Denise L Cecil, John B Liao, Yushe Dang, Andrew L Coveler, Angela Kask, Yi Yang, Jennifer S Childs, Doreen M Higgins, Mary L Disis
Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)